Tech Company Financing Transactions
GITR Funding Round
GITR closed a $1.3 million financing round on 1/5/2012. Investors included private investors.
Transaction Overview
Company Name
Announced On
1/5/2012
Transaction Type
Venture Equity
Amount
$1,250,000
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed. SEC regulatory filing.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
47 Thorndike St. B1-1
Cambridge, MA 02141
USA
Cambridge, MA 02141
USA
Phone
Email Address
Not Recorded
Overview
The company is developing novel approaches to immunomodulatory responses to cancer.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Augustine Lawlor
Browse more venture capital transactions:
Prev: 1/5/2012: Aisle50 venture capital transaction
Next: 1/6/2012: Healthx venture capital transaction
Share this article
About Our Venture Capital Transactions Database
Our team works diligently to report on funding rounds that are announced publicly. VC transactions reported here are derived from a variety of public sources. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs